Rapid Micro Biosystems to Attend Investor Conferences in New York

LEXINGTON, Mass., Sept. 04, 2026 /CourierPR/ -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID), a leading life sciences technology company, will participate in several upcoming investor conferences to showcase its mission-critical automation solutions aimed at enhancing the manufacturing and release of healthcare products.

The company will attend the Lake Street’s 10th Annual Best Ideas Growth (BIG) Conference on September 10, 2026, in New York, NY. Here, Rapid Micro Biosystems will conduct one-on-one meetings with investors to discuss its innovative technologies and growth strategies.

Another highlight for investors will be the 5th Annual Roth Healthcare Opportunities Conference, where Rapid Micro Biosystems will participate in one-on-one meetings on September 29, 2026, in New York, NY. The company’s flagship Growth Direct system, which automates and modernizes the microbial quality control testing in pharmaceutical manufacturing, will be a key focus of these discussions.

Rapid Micro Biosystems, headquartered in Lexington, Massachusetts, with manufacturing facilities in Lowell, Massachusetts, also has global operations in Switzerland, Germany, and the Netherlands. The company’s Growth Direct system is designed to bring quality control labs directly to the manufacturing floor, providing faster, more accurate results, increased efficiency, and better compliance with data integrity regulations. This technology is crucial for the rapid and safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables.